Literature DB >> 22897169

Haemodynamic effects of non-invasive ventilation in patients with obesity-hypoventilation syndrome.

Olalla Castro-Añón1, Rafael Golpe, Luis A Pérez-de-Llano, María Jesús López González, Edgar J Escalona Velasquez, Ruth Pérez Fernández, Ana Testa Fernández, Arturo González Quintela.   

Abstract

BACKGROUND AND
OBJECTIVE: Although it has been reported that pulmonary hypertension is more frequent in patients with obesity-hypoventilation syndrome than in patients with 'pure' obstructive sleep apnoea syndrome, little is known about the haemodynamic repercussions of this entity. The aim was to describe the haemodynamic status, as assessed by echocardiography and 6-min walk test (6MWT), of patients with a newly diagnosed, most severe form of obesity-hypoventilation syndrome, and to evaluate the impact of non-invasive ventilation in these patients.
METHODS: A prospective, descriptive, and single-centre follow-up study was conducted. At baseline, patients underwent echocardiography, spirometry, static lung volume measurement, 6MWT, overnight pulse-oximetry and polygraphic recording. Changes in echocardiography and 6MWT were assessed after 6 months of non-invasive ventilation. Right ventricular overload was defined on the basis of right ventricular dilatation, hypokinesis, paradoxical septal motion and/or pulmonary hypertension.
RESULTS: Thirty patients (20 women; mean age 69 ± 11) were tested. The percentage of patients with right ventricular overload did not change significantly after non-invasive ventilation (43.3-41.6%; P = 0.24). In patients with right ventricular overload at diagnosis, pulmonary artery systolic pressure decreased significantly at six months (58 ± 11 to 44 ± 12 mm Hg; P = 0.014), and mean distance on 6MWT increased from 350 ± 110 to 426 ± 78 m (P = 0.006), without significant changes in body mass index.
CONCLUSIONS: Right ventricular overload is a frequent finding in patients with the most severe form of obesity-hypoventilation syndrome. Treatment with non-invasive ventilation is associated with a decrease in pulmonary artery systolic pressure at six months and an increase in the distance covered during the 6MWT.
© 2012 The Authors. Respirology © 2012 Asian Pacific Society of Respirology.

Entities:  

Mesh:

Year:  2012        PMID: 22897169     DOI: 10.1111/j.1440-1843.2012.02252.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  12 in total

1.  The prevalence of pulmonary hypertension in patients with obesity hypoventilation syndrome: a prospective observational study.

Authors:  Aljohara S Almeneessier; Samar Z Nashwan; Mostafa Q Al-Shamiri; Seithikurippu R Pandi-Perumal; Ahmed S BaHammam
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

2.  Obesity Hypoventilation Syndrome.

Authors:  Safal Shetty; Sairam Parthasarathy
Journal:  Curr Pulmonol Rep       Date:  2015-03-01

3.  Risk factors associated with pulmonary hypertension in obesity hypoventilation syndrome.

Authors:  Juan F Masa; Iván D Benítez; Shahrokh Javaheri; Maria Victoria Mogollon; Maria Á Sánchez-Quiroga; Francisco J Gomez de Terreros; Jaime Corral; Rocio Gallego; Auxiliadora Romero; Candela Caballero-Eraso; Estrella Ordax-Carbajo; María F Troncoso; Mónica González; Soledad López-Martín; José M Marin; Sergi Martí; Trinidad Díaz-Cambriles; Eusebi Chiner; Carlos Egea; Javier Barca; Ferrán Barbé; Babak Mokhlesi
Journal:  J Clin Sleep Med       Date:  2022-04-01       Impact factor: 4.062

Review 4.  Group 3 Pulmonary Hypertension: From Bench to Bedside.

Authors:  Navneet Singh; Peter Dorfmüller; Oksana A Shlobin; Corey E Ventetuolo
Journal:  Circ Res       Date:  2022-04-28       Impact factor: 23.213

Review 5.  Domiciliary noninvasive ventilation for chronic respiratory diseases.

Authors:  Vikas Marwah; Raja Dhar; Robin Choudhary; Mark Elliot
Journal:  Med J Armed Forces India       Date:  2022-09-29

Review 6.  [Cardiac effects of noninvasive ventilation].

Authors:  S Walterspacher; H Woehrle; M Dreher
Journal:  Herz       Date:  2014-02       Impact factor: 1.443

7.  Paradoxical worsening of hypoxemia in a patient treated by noninvasive positive pressure ventilation for obesity hypoventilation syndrome with concomitant obstructive sleep apnea: a case report.

Authors:  Carole de Picciotto; Coraline Duménil; Olivier Auzel; Violaine Giraud; Marcel Bonay
Journal:  J Med Case Rep       Date:  2017-08-23

8.  Impact of High-Intensity-NIV on the heart in stable COPD: a randomised cross-over pilot study.

Authors:  Marieke Leontine Duiverman; Petra Maagh; Friederike Sophie Magnet; Claudia Schmoor; Maria Paola Arellano-Maric; Axel Meissner; Jan Hendrik Storre; Peter Jan Wijkstra; Wolfram Windisch; Jens Callegari
Journal:  Respir Res       Date:  2017-05-02

9.  Neural respiratory drive and cardiac function in patients with obesity hypoventilation syndrome following initiation of non-invasive ventilation.

Authors:  Angelo Onofri; Maxime Patout; Georgios Kaltsakas; Elodie Lhuillier; Sitali Mushemi-Blake; Gill Arbane; Martino F Pengo; Philip Marino; Joerg Steier
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

10.  Comparison of exercise capacity in COPD and other etiologies of chronic respiratory failure requiring non-invasive mechanical ventilation at home: retrospective analysis of 1-year follow-up.

Authors:  Cuneyt Salturk; Zuhal Karakurt; Huriye Berk Takir; Merih Balci; Feyza Kargin; Ozlem Yazıcıoglu Mocin; Gokay Gungor; Ipek Ozmen; Selahattin Oztas; Murat Yalcinsoy; Ruya Evin; Murat Ozturk; Nalan Adiguzel
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.